Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Comparison of Pramipexole and Citalopram in the Treatment of Depression in Parkinson's Disease: A Randomized Parallel-Group Trial Publisher



Ziaei E1 ; Ardestani PE1 ; Chitsaz A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2022


Abstract

Background: Depression is one of the most common neuropsychiatric symptoms in Parkinson's disease (PD). There is little evidence to guide depression treatment in these patients. The aim of this study was to compare citalopram and pramipexole in reducing depressive symptoms in patients with PD. Materials and Methods: In the present 8-week randomized trial, we compared the efficacy of pramipexole versus citalopram in the treatment of depression in PD patients. For this purpose, 44 PD patients with depression randomly received open-label oral citalopram tablets or pramipexole and their depression, quality of life, and daytime sleepiness scores were evaluated at baseline and after the 8-week trial period. Results: The median age of the patients was 64 years, and about 85% of them were male in both groups. The Beck Depression Inventory score, Parkinson's disease summary index (PDSI), and Epworth Sleepiness Scale were significantly decreased (P < 0.05) in both citalopram and pramipexole groups throughout this period and without significant difference (P > 0.05) between these two groups, except for PDSI score which showed significant improvement in pramipexole group compared with citalopram group (P < 0.0001, r = 0.319). There were neither serious adverse effects nor treatment discontinuation due to the adverse effects. Conclusion: The results indicated that both citalopram and pramipexole were effective in the alleviation of depression and improving the quality of life in PD patients; however, pramipexole was seemed to be slightly more beneficial on quality of life in these patients. Therefore, pramipexole seems to be an effective treatment for depression in addition to its benefits for motor symptoms of PD patients. © 2022 Wolters Kluwer Medknow Publications. All rights reserved.
Related Docs
View other Related Docs
1. Comparison of the Effectiveness of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson’S Disease, Current Journal of Neurology (2024)
2. Sleep Quality in Patients With Parkinson's Disease, Journal of Isfahan Medical School (2012)
3. Lavender and Dodder Combined Herbal Syrup Versus Citalopram in Major Depressive Disorder With Anxious Distress: A Double-Blind Randomized Trial, Journal of Integrative Medicine (2020)
4. A Comparison of Effectiveness of Dohsa-Hou and the Alexander Technique on Happiness, Social Adjustment, Hope, Mental Health, and Quality of Life in Patients With Parkinson's Disease, Japanese Psychological Research (2018)
5. Investigating the Effect of Home-Based Physical Activity Schedule on the Quality of Life, Sleep Quality, and Mood of the Elderly at Risk of Depression As Compared to the Control Group, Advanced Biomedical Research (2021)
6. Efficacy of Preladenant in Improving Motor Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis, IBRO Neuroscience Reports (2024)
7. The Effect of Dracocephalum Extract on Sleep Quality in Post-Menopausal Women: A Randomized Placebo-Controlled Trial, Iranian Journal of Psychiatry (2022)
8. Sertraline As an Add-On Treatment for Depressive Symptoms in Stable Schizophrenia: A Double-Blind Randomized Controlled Trial, Journal of Research in Medical Sciences (2012)
Experts (# of related papers)
View all Related Experts
Ahmad Chitsaz (4)
Mohammad Reza Maracy (2)
Other Related Docs
9. A Comparison of the Effectiveness of Three Drug Regimens on Cognitive Performance of Patients With Parkinson's Disease, Psicologica (2013)
10. The Effects of Alcoholic Extract of Saffron (Crocus Satious L.) on Mild to Moderate Comorbid Depression-Anxiety, Sleep Quality, and Life Satisfaction in Type 2 Diabetes Mellitus: A Double-Blind, Randomized and Placebo-Controlled Clinical Trial, Complementary Therapies in Medicine (2018)
11. Memantine Add on to Citalopram in Elderly Pa Tients With Depression: A Double-Blind Placebo-Controlled Study, Journal of Research in Medical Sciences (2014)